Cost effectiveness of newborn screening for cystic fibrosis: A simulation study

Léon Nshimyumukiza, Antoine Bois, Patrick Daigneault, Larry C. Lands, Anne‐Marie Laberge, Diane Fournier, Julie Duplantie, Yves Giguère, Jean Gekas, Christian Gagné, François Rousseau, Daniel ReinharzJournal of Cystic Fibrosis 2013 · DOI

Abstract

This study suggests that NBS for cystic fibrosis is a cost-effective strategy compared to the absence of NBS. The IRT-PAP newborn screening algorithm with an IRT cutoff at the 96th percentile is the most cost effective NBS approach for Quebec.
BibTeX
@article{nshimyumukiza2013cost,
  author = {Léon Nshimyumukiza and Antoine Bois and Patrick Daigneault and Larry C. Lands and Anne‐Marie Laberge and Diane Fournier and Julie Duplantie and Yves Giguère and Jean Gekas and Christian Gagné and François Rousseau and Daniel Reinharz},
  title = {{Cost effectiveness of newborn screening for cystic fibrosis: A simulation study}},
  journal = {Journal of Cystic Fibrosis},
  year = {2013},
  doi = {10.1016/j.jcf.2013.10.012},
}

Loading related content...

Figure